333 related articles for article (PubMed ID: 3553166)
1. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment.
Reisberg B; Borenstein J; Salob SP; Ferris SH; Franssen E; Georgotas A
J Clin Psychiatry; 1987 May; 48 Suppl():9-15. PubMed ID: 3553166
[TBL] [Abstract][Full Text] [Related]
2. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.
De Deyn PP; Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():19-22. PubMed ID: 11584983
[TBL] [Abstract][Full Text] [Related]
3. Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics.
Gleason RP; Schneider LS
J Clin Psychiatry; 1990 Mar; 51(3):115-8. PubMed ID: 1968457
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
5. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
[TBL] [Abstract][Full Text] [Related]
7. [Behavioral pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD): Spanish validation].
Boada M; Tárraga L; Modinos G; Diego S; Reisberg B
Neurologia; 2006; 21(1):19-25. PubMed ID: 16525922
[TBL] [Abstract][Full Text] [Related]
8. Behavioral outcomes in clinical trials for Alzheimer disease.
Ferris SH; Mackell JA
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 4():S10-5. PubMed ID: 9339267
[TBL] [Abstract][Full Text] [Related]
9. [In Alzheimer's disease, the clinical expression of behavioral and psychological signs and symptoms is early and specific of neuropathological stages].
Michel BF; Luciani V; Geda YE; Sambuchi N; Paban V; Azorin JM
Encephale; 2010 Sep; 36(4):314-25. PubMed ID: 20850603
[TBL] [Abstract][Full Text] [Related]
10. Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of Alzheimer type.
Fujikawa T; Takahashi T; Kinoshita A; Kajiyama H; Kurata A; Yamashita H; Yamawaki S
Neuropsychobiology; 2004; 49(4):201-4. PubMed ID: 15118358
[TBL] [Abstract][Full Text] [Related]
11. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
Harwood DG; Sultzer DL; Wheatley MV
Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):83-8. PubMed ID: 10780626
[TBL] [Abstract][Full Text] [Related]
12. Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia.
Skjerve A; Holsten F; Aarsland D; Bjorvatn B; Nygaard HA; Johansen IM
Psychiatry Clin Neurosci; 2004 Aug; 58(4):343-7. PubMed ID: 15298644
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of perospirone on aggressive behavior associated with dementia.
Sato S; Mizukami K; Moro K; Tanaka Y; Asada T
Psychiatry Clin Neurosci; 2006 Feb; 60(1):106-9. PubMed ID: 16472367
[TBL] [Abstract][Full Text] [Related]
14. [The clinical picture and stability of non-cognitive symptoms in patients with Alzheimer's disease].
Haupt M; Jänner M; Stierstorfer A; Kretschmar C
Fortschr Neurol Psychiatr; 1998 May; 66(5):233-40. PubMed ID: 9653639
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.
Ito T; Meguro K; Akanuma K; Meguro M; Lee E; Kasuya M; Ishii H; Mori E
J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584
[TBL] [Abstract][Full Text] [Related]
16. Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics.
Lemke MR
J Clin Psychiatry; 1995 Aug; 56(8):354-7. PubMed ID: 7635851
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients.
Shimabukuro J; Awata S; Matsuoka H
Psychiatry Clin Neurosci; 2005 Jun; 59(3):274-9. PubMed ID: 15896220
[TBL] [Abstract][Full Text] [Related]
18. Haloperidol versus thioridazine in the treatment of behavioral symptoms in senile dementia of the Alzheimer's type: preliminary findings.
Steele C; Lucas MJ; Tune L
J Clin Psychiatry; 1986 Jun; 47(6):310-2. PubMed ID: 3711028
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers.
Finkel SI
J Clin Psychiatry; 2001; 62 Suppl 21():3-6. PubMed ID: 11584987
[TBL] [Abstract][Full Text] [Related]
20. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
